1. Home
  2. IVZ vs GMED Comparison

IVZ vs GMED Comparison

Compare IVZ & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVZ
  • GMED
  • Stock Information
  • Founded
  • IVZ 1935
  • GMED 2003
  • Country
  • IVZ United States
  • GMED United States
  • Employees
  • IVZ N/A
  • GMED N/A
  • Industry
  • IVZ Investment Managers
  • GMED Medical/Dental Instruments
  • Sector
  • IVZ Finance
  • GMED Health Care
  • Exchange
  • IVZ Nasdaq
  • GMED Nasdaq
  • Market Cap
  • IVZ 7.0B
  • GMED 8.1B
  • IPO Year
  • IVZ 1995
  • GMED 2012
  • Fundamental
  • Price
  • IVZ $21.22
  • GMED $53.40
  • Analyst Decision
  • IVZ Hold
  • GMED Buy
  • Analyst Count
  • IVZ 16
  • GMED 13
  • Target Price
  • IVZ $18.48
  • GMED $90.00
  • AVG Volume (30 Days)
  • IVZ 7.5M
  • GMED 1.7M
  • Earning Date
  • IVZ 07-22-2025
  • GMED 08-07-2025
  • Dividend Yield
  • IVZ 3.95%
  • GMED N/A
  • EPS Growth
  • IVZ N/A
  • GMED 145.70
  • EPS
  • IVZ 1.24
  • GMED 1.34
  • Revenue
  • IVZ $6,153,100,000.00
  • GMED $2,510,810,000.00
  • Revenue This Year
  • IVZ N/A
  • GMED $15.47
  • Revenue Next Year
  • IVZ $3.97
  • GMED $8.53
  • P/E Ratio
  • IVZ $17.17
  • GMED $39.68
  • Revenue Growth
  • IVZ 6.02
  • GMED 32.26
  • 52 Week Low
  • IVZ $11.60
  • GMED $51.87
  • 52 Week High
  • IVZ $21.69
  • GMED $94.93
  • Technical
  • Relative Strength Index (RSI)
  • IVZ 86.51
  • GMED 31.95
  • Support Level
  • IVZ $16.49
  • GMED $51.87
  • Resistance Level
  • IVZ $17.53
  • GMED $57.99
  • Average True Range (ATR)
  • IVZ 0.63
  • GMED 1.55
  • MACD
  • IVZ 0.39
  • GMED -0.40
  • Stochastic Oscillator
  • IVZ 88.77
  • GMED 5.44

About IVZ Invesco Ltd

Invesco provides investment-management services to retail (67% of managed assets) and institutional (33%) clients. At the end of April 2025, the firm had $1.840 trillion in assets under management spread among its equity (57% of AUM), balanced (3%), fixed-income (22%), alternative investment (7%), and money market (11%) operations. Passive products account for 43% of Invesco's total AUM, including 65% of the company's equity operations and 15% of its fixed-income platform. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 30% of its AUM sourced from Europe, Africa, and the Middle East (15%) and Asia (15%).

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Share on Social Networks: